Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
₹12 Cr
P/E Ratio
51.07
P/B Ratio
0.56
Industry P/E
32.09
Debt to Equity
0
ROE
-7.44 %
ROCE
-4.24 %
Div. Yield
0 %
Book Value
20.73
EPS
0.23
CFO
₹-1.83 Cr
EBITDA
₹1.67 Cr
Net Profit
₹4.97 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Decipher Labs
| -21.87 | -0.34 | -24.74 | -26.03 | -41.69 | -12.58 | 1.10 |
|
BSE Healthcare
| -7.68 | 6.11 | -2.04 | 19.11 | 18.77 | 22.70 | 8.84 |
|
BSE Small Cap
| -12.49 | 9.35 | -8.34 | 5.55 | 17.55 | 35.38 | 15.06 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Decipher Labs
| -15.68 | -44.75 | -77.42 | 287.76 | 14.61 | 38.39 | -0.57 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 733.60 | 6,652.58 | 26.68 | 13.8 | |
| 486.35 | 7,653.28 | -- | 0.11 | |
| 2,322.20 | 9,511.53 | 78.36 | 12.96 | |
| 431.60 | 5,319.81 | 71.34 | 6.24 |
No Review & Analysis are available.
Combat Drugs Limited manufactures and markets pharmaceutical formulations in India. The company offers its products in various forms, such as tablets, capsules, liquid orals, and ointments. The company was founded in 1986 and is based in Hyderabad,... India. Read more
Incorporated
1986
Chairman
--
Managing Director
--
Group
MNC
Headquarters
Hyderabad, Telangana
Website
Looking for more details about Decipher Labs Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Decipher Labs Ltd stood at ₹ 31 Cr as on 31-Dec-24
The share price of Decipher Labs Ltd is ₹11.68 (BSE) as of 17-Apr-2025 IST. Decipher Labs Ltd has given a return of -41.69% in the last 3 years.
Decipher Labs Ltd has a market capitalisation of ₹ 12 Cr as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Decipher Labs Ltd is 0.56 times as on 17-Apr-2025, a 85% discount to its peers’ median range of 3.70 times.
The P/E ratio of Decipher Labs Ltd is 51.07 times as on 17-Apr-2025, a 59% premium to its peers’ median range of 32.09 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Decipher Labs Ltd and enter the required number of quantities and click on buy to purchase the shares of Decipher Labs Ltd.
Combat Drugs Limited manufactures and markets pharmaceutical formulations in India. The company offers its products in various forms, such as tablets, capsules, liquid orals, and ointments. The company was founded in 1986 and is based in Hyderabad, India.
The promoter of Decipher Labs Ltd is AJJARAPU JANAKIRAM. AJJARAPU JANAKIRAM owns 16.43 per cent of the total equity. The chairman of the company is ..
There is no promoter pledging in Decipher Labs Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
9,512
|
|
|
7,653
|
|
|
6,653
|
|
|
5,320
|
| Decipher Labs Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
1.06
|
|
Operating margin(%)
|
0.34
|
|
Net Margin(%)
|
0.76
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Decipher Labs Ltd was ₹0 Cr.
₹0.38
(
